Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer-Reference-Cited by-同舟云学术

Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer

Published:2017-12 Issue: Volume:110 Page:51-61
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Li Xin,Yang Changyong,Wan Hong,Zhang Ge,Feng Jun,Zhang Lei,Chen Xiaoyan,Zhong Dafang,Lou Liguang,Tao Weikang,Zhang Lianshan

Funder

National New Drug Key Program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects;Abbas;Br. J. Clin. Pharmacol.,2011

2. HER2-directed therapy: current treatment options for HER2-positive breast cancer;Ahmed;Breast Cancer,2015

3. Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer;Bose;Expert Opin. Invest. Drugs,2009

4. Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer;Burstein;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2010

5. Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer;Canonici;Oncotarget,2013

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced technologies for screening and identifying covalent inhibitors;TrAC Trends in Analytical Chemistry;2024-09

2. Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases;Frontiers in Pharmacology;2024-08-19

3. Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments;Frontiers in Pharmacology;2024-08-13

4. Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study;Clinical Breast Cancer;2024-08

5. Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer;World Journal of Gastrointestinal Oncology;2024-06-15